Literature DB >> 12208339

Endothelial cell injury in venule and capillary induced by contrast ultrasonography.

Nobuhiko Kobayashi1, Takanori Yasu, Satoshi Yamada, Nobuki Kudo, Masatoshi Kuroki, Masanobu Kawakami, Kunio Miyatake, Muneyasu Saito.   

Abstract

The aim of the present study was to test the hypothesis that microvascular endothelial cells (EC) are subject to the bioeffects induced by contrast ultrasound (US) because of their proximity to the circulating microbubbles. We examined EC injury in each microvessel section (arteriole, capillary or venule) in rat mesenteries among the following five groups: three controls (sham operation, microbubble injection alone, US exposure with saline injection), and two contrast-US groups (US exposure at a 1-Hz or 30-Hz frame rate with microbubble injection). Propidium iodide (PI), a fluorescent indicator of cell injury, was employed to visualize impaired EC. PI-positive nuclei were equally few among the three controls. Contrast-US increased PI-positive cells in capillaries (1-Hz frame rate, 2.4 +/- 2.2 cells per 0.1-mm vessel length, p = 0.09; 30-Hz frame rate, 4.3 +/- 1.8 cells, p < 0.01) and in venules (1-Hz frame rate, 4.1 +/- 2.5 cells, p < 0.05; 30-Hz frame rate, 13.8 +/- 3.6 cells, p < 0.01) compared with sham operation (0.10 +/- 0.22 cells). The finding indicates that diagnostic contrast US potentially causes EC injury, particularly in venules and capillaries.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12208339     DOI: 10.1016/s0301-5629(02)00532-x

Source DB:  PubMed          Journal:  Ultrasound Med Biol        ISSN: 0301-5629            Impact factor:   2.998


  15 in total

Review 1.  Safety of ultrasound contrast agents.

Authors:  Jarl A Jakobsen; Raymond Oyen; Henrik S Thomsen; Sameh K Morcos
Journal:  Eur Radiol       Date:  2005-01-21       Impact factor: 5.315

Review 2.  Ultrasound-biophysics mechanisms.

Authors:  William D O'Brien
Journal:  Prog Biophys Mol Biol       Date:  2006-08-08       Impact factor: 3.667

3.  Contrast ultrasound imaging of the aorta alters vascular morphology and circulating von Willebrand factor in hypercholesterolemic rabbits.

Authors:  Brendon W Smith; Douglas G Simpson; Sandhya Sarwate; Rita J Miller; James P Blue; Alexander Haak; William D O'Brien; John W Erdman
Journal:  J Ultrasound Med       Date:  2012-05       Impact factor: 2.153

4.  Targeted long-term venous occlusion using pulsed high-intensity focused ultrasound combined with a pro-inflammatory agent.

Authors:  Yufeng Zhou; Jasmine Zia; Cinderella Warren; Frank L Starr; Andrew A Brayman; Lawrence A Crum; Joo Ha Hwang
Journal:  Ultrasound Med Biol       Date:  2011-08-06       Impact factor: 2.998

5.  Safety and bio-effects of ultrasound contrast agents.

Authors:  Gail ter Haar
Journal:  Med Biol Eng Comput       Date:  2009-07-14       Impact factor: 2.602

6.  Characteristic microvessel relaxation timescales associated with ultrasound-activated microbubbles.

Authors:  Hong Chen; Andrew A Brayman; Thomas J Matula
Journal:  Appl Phys Lett       Date:  2012-10-19       Impact factor: 3.791

Review 7.  [Ultrasound contrast agents. Pharmaceutical drug safety and bioeffects].

Authors:  M Krix; J W Jenne
Journal:  Radiologe       Date:  2007-09       Impact factor: 0.635

8.  Preliminary observations on the spatial correlation between short-burst microbubble oscillations and vascular bioeffects.

Authors:  Hong Chen; Andrew A Brayman; Andrew P Evan; Thomas J Matula
Journal:  Ultrasound Med Biol       Date:  2012-10-12       Impact factor: 2.998

Review 9.  Ultrasound contrast microbubbles in imaging and therapy: physical principles and engineering.

Authors:  Shengping Qin; Charles F Caskey; Katherine W Ferrara
Journal:  Phys Med Biol       Date:  2009-02-19       Impact factor: 3.609

10.  Nephron injury induced by diagnostic ultrasound imaging at high mechanical index with gas body contrast agent.

Authors:  Alun R Williams; Roger C Wiggins; Bryan L Wharram; Meera Goyal; Chunyan Dou; Kent J Johnson; Douglas L Miller
Journal:  Ultrasound Med Biol       Date:  2007-05-16       Impact factor: 2.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.